"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","treatment_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell line:ch1","isolated by ultracentrifugation:ch1","treatment:ch1"
"GSM1614720","smoking-induced primary HBEC-derived EVs","GSM1614720","Public on Feb 19 2018","Feb 19 2015","Feb 19 2018","RNA","1","Exosome","Homo sapiens","cell line: HBEC","treatment: CSE (+)","isolated by ultracentrifugation: extracellular vesicles (EVs)","Cigarette smoke extract (CSE) was prepared for smoking exposure model in vitro.聽Forty milliliters of cigarette smoke was drawn into the syringe and slowly bubbled into sterile serum-free cell culture media in a 15-ml BD falcon tube. One cigarette was used for the preparation of 10 mL of solution. CSE solution was filtered (0.22 渭m) to remove insoluble particles and was designated as a 100% CSE solution. We analyzed the role of CSE induced HBEC-derived EVs in the airway microenvironment. After HBECs were incubated in the non-FBS containing medium with or without a low-concentration CSE (1.0%) for 2 days, we collected conditioned medium (on day 4, 6) and isolated EVs by ultracentrifugation.","total RNA","Total RNA was extracted from EVs using QIAzol and the miRNeasy Mini Kit (Qiagen) according to the manufacturer鈥檚 protocol.","Cy3","RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray version 2 8x15K (G4470B Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Sample name: CSE (+)","Human bronchial epithelial cell","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 046064_D_F_20121223) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL18044","Yu,,Fujita","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center Research Institute","5-1-1 Tsukiji","chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1614nnn/GSM1614720/suppl/GSM1614720_CSE_+_.txt.gz","62344","HBEC","extracellular vesicles (EVs)","CSE (+)"
"GSM1614721","non-treated primary HBEC-derived EVs","GSM1614721","Public on Feb 19 2018","Feb 19 2015","Feb 19 2018","RNA","1","Exosome","Homo sapiens","cell line: HBEC","treatment: CSE (-)","isolated by ultracentrifugation: extracellular vesicles (EVs)","Cigarette smoke extract (CSE) was prepared for smoking exposure model in vitro.聽Forty milliliters of cigarette smoke was drawn into the syringe and slowly bubbled into sterile serum-free cell culture media in a 15-ml BD falcon tube. One cigarette was used for the preparation of 10 mL of solution. CSE solution was filtered (0.22 渭m) to remove insoluble particles and was designated as a 100% CSE solution. We analyzed the role of CSE induced HBEC-derived EVs in the airway microenvironment. After HBECs were incubated in the non-FBS containing medium with or without a low-concentration CSE (1.0%) for 2 days, we collected conditioned medium (on day 4, 6) and isolated EVs by ultracentrifugation.","total RNA","Total RNA was extracted from EVs using QIAzol and the miRNeasy Mini Kit (Qiagen) according to the manufacturer鈥檚 protocol.","Cy3","RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray version 2 8x15K (G4470B Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Sample name: CSE (-)","Human bronchial epithelial cell","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 046064_D_F_20121223) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL18044","Yu,,Fujita","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center Research Institute","5-1-1 Tsukiji","chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1614nnn/GSM1614721/suppl/GSM1614721_CSE_-_.txt.gz","62344","HBEC","extracellular vesicles (EVs)","CSE (-)"
